Navigation Links
Decisions On End-of-Life Treatment Found To Vary From Country To Country

In a study conducted in Switzerland it was seen that the frequency of withholding or withdrawing life-prolonging treatment // at the end of a patient’s life varies greatly among European countries. The study also showed that modern medicine provided unprecedented opportunities in diagnostics and treatment to save and sustain life. However, in some situations at the end of a patient’s life, physicians may refrain from using all possible measures to prolong life.

To study the different types of treatment withheld or withdrawn from patients, researchers sent physicians questionnaires about their decision-making process of the treatment. Physicians were asked whether or not they withheld or withdrew medical treatment and if so, what kind of treatment was it?

On analyzing the results of the questionnaire it was found that decisions not to treat were reported for 41 percent of deaths in Switzerland, 30 percent in the Netherlands, 27 percent in Belgium, 23 percent in Denmark, 22 percent in Sweden, and 6 percent in Italy and in all of the countries except Italy, medicine was the treatment most forgone.

Thus in conclusion researchers say based on their findings it was seen that low-technology interventions, such as medication or hydration or nutrition, were the most frequently forgone.
'"/>




Page: 1

Related medicine news :

1. Pharma Companies May Influence The Decisions Of Medical Students
2. Critical Decisions Have To Be Taken By Mothers Of Premature Babies
3. Distinct Brain Sections Are Activated While Making Risky Decisions
4. Image-Guided Biopsy Can Alter Clinical Decisions In Kidney Patients
5. Insight Into The Risky Health Decisions On Bird Flu
6. Fair Sex Thought to Fare Well with Medical Decisions
7. "Active" Brain Makes Rational Decisions!!
8. Many Kidney Specialists Feel Unprepared for End-of-Life Decisions
9. Terminally Ill Patients Asked To Depute People To Make Decisions
10. Many Kidney Specialists Feel Unprepared for End-of-Life Decisions
11. Advances in Treatment of Cataracts
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/27/2016)... York, NY (PRWEB) , ... May 27, 2016 , ... ... campaign returns for a third time to shed lights on the variety of topics ... and inspirational stories, “Nurse Appreciation” tackles why this career has gone from being in ...
(Date:5/27/2016)... ... May 27, 2016 , ... An educational campaign aimed at ... stories, courtesy of awareness-driven celebrities and thought leaders. It also provides insight to ... industry leaders such as Bioness. , As patients feel increasingly concerned about ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed at nurses and ... interest stories, courtesy of leaders in the nursing and health care industry. It ... leading advocates and associations—namely Jones & Bartlett Learning. , Jones & Bartlett Learning ...
(Date:5/27/2016)... ... May 27, 2016 , ... ... the pharmaceutical, medical and food industries. Aside from its GMP accreditation, Validation Center ... proof of successfully certified products, services and staff. , Validation Center is ISO17025 ...
(Date:5/26/2016)... , ... May 26, 2016 , ... W.S. Badger ... has been honored with a 2016 When Work Works Award for its use of ... of the national When Work Works project administered by the Families and Work Institute ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... the necessity of health literacy within the technology advancement of diagnostic imaging. According to a ... majority of oncology patients undergo imaging screenings without understanding the nuanced risks associated with ... ... ... Diagnostic Imaging Ampronix ...
(Date:5/27/2016)... , May 27, 2016 ... innovative biopharmaceutical company focused on late-stage drug development, ... Dexcel Pharma of pivotal batches required for ... Drug Administration (FDA). This follows Kitov,s announcement ... III trial successfully met its primary efficacy endpoint. ...
(Date:5/26/2016)... , May 26, 2016 ... market growth is the emergence of new treatments. Cardax, ... therapies for osteoarthritis treatment. The therapy is expected to ... Arthritis Research UK is conducting studies to develop new ... study, where the genes involved in osteoarthritis are being ...
Breaking Medicine Technology: